Skip to content

10x Genomics, Inc.

TXG

CIK 0001770787

← back to feed
Revenue (TTM)
$627.64M
+5.2% YoY Q1 Mar 2026
Net Income (TTM)
−$40.76M
+76.2% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$0.32
+77.0% YoY Q1 Mar 2026
Gross Margin
69.6%
Q1 Mar 2026
Operating Margin
-9.3%
Q1 Mar 2026
Net Margin
-6.5%
Q1 Mar 2026
Free Cash Flow (TTM)
$29.66M
Q1 Mar 2026
Cash
$344.07M
Q1 Mar 2026
Total Debt
$0
Q1 Mar 2026
Shares Outstanding
127.69M sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings